Cell-free nucleic acids as potential markers for preeclampsia.
about
Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and diseaseA Dormant Microbial Component in the Development of PreeclampsiaMeta-Analysis of Placental Transcriptome Data Identifies a Novel Molecular Pathway Related to PreeclampsiaRepeated failed non-invasive prenatal testing in a woman with immune thrombocytopenia and antiphospholipid syndrome: lessons learnt.Follicular fluid oocyte/cumulus-free DNA concentrations as a potential biomolecular marker of embryo quality and IVF outcome.Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restrictionThe use of cffDNA in fetal sex determination during the first trimester of pregnancy of female DMD carriers.Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing.The secret language of destiny: stress imprinting and transgenerational origins of diseaseChorioamnionitis Occurring in Women With Preterm Rupture of the Fetal Membranes Is Associated With a Dynamic Increase in mRNAs Coding Cytokines in the Maternal Circulation.Epigenetics and microRNAs in preeclampsia.Oxidized extracellular DNA as a stress signal in human cellsQuantification of maternal serum cell-free fetal DNA in early-onset preeclampsia.Non-invasive Prenatal Testing: Technologies, Clinical Assays and Implementation Strategies for Women's Healthcare Practitioners.DNA methylation testing and marker validation using PCR: diagnostic applications.Multiplexed nucleic acid-based assays for molecular diagnostics of human disease.What does next-generation sequencing mean for prenatal diagnosis?Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic review.Fetal DNA in maternal plasma in preeclamptic pregnancies.Identification of Early-Onset Preeclampsia-Related Genes and MicroRNAs by Bioinformatics Approaches.Non-invasive prenatal diagnosis of β-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis.Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis.Roles of microRNA-34a in the pathogenesis of placenta accreta.Potential confounding factors in measurement of specific cell-free seminal mRNAs and microRNAs derived from human reproductive organs.Placenta-derived exosomes: potential biomarkers of preeclampsia.The relationship between maternal serum prenatal screening combined with epidemiological study and early onset preeclampsia.Blood laboratory testing for early prediction of preeclampsia: chasing the finish line or at the starting blocks?Elevated plasma levels of hypermethylated RASSF1A gene sequences in pregnant women with intrahepatic cholestasis.Circulating cell-free DNA concentration and DNase I activity of peripheral blood plasma change in case of pregnancy with intrauterine growth restriction compared to normal pregnancy.Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.Non-invasive prenatal diagnosis of beta-thalassemia by semiconductor sequencing: a feasibility study in the sardinian population.Extracellular GC-rich DNA activates TLR9- and NF-kB-dependent signaling pathways in human adipose-derived mesenchymal stem cells (haMSCs).Recent advances in the diagnosis and management of pre-eclampsia.Excessive Neutrophil Activity in Gestational Diabetes Mellitus: Could It Contribute to the Development of Preeclampsia?Fetal Nucleic Acids in Maternal Circulation: A Genetic Resource for Noninvasive Prenatal Diagnosis
P2860
Q26991553-B7D4B44B-DC39-4CF5-8A74-6ECB7430718AQ28069689-F61EF940-6972-4CE3-B0AD-C472B9DCD5B3Q30980239-344EAEE5-BF3C-41E5-AB2A-E55E5364FA52Q33437396-CEFC7058-AEEF-4336-BC63-53EEF0AD5D64Q33849926-AB9EBFB9-CC63-492D-ABBB-4B7AF971C70AQ34277918-B98DE9B5-3EFB-4181-8CF5-1E2EA8ACA400Q34377867-4777FFAD-2AF2-4687-A3FE-D0CB2E11CE72Q34675862-B9BC7810-2AB1-470B-A764-7A411084FB0AQ36005293-8EE79711-6B8F-4B7B-BE63-196D1A310239Q36047180-A5C38984-FDDD-4B21-B2FD-968DA6C0F201Q36103371-11ED78B1-0746-4228-B043-6DBB5E2222BCQ36711791-850E49DD-60D8-480A-970A-00BC9431C793Q36820478-6F8453D5-674A-49A1-BD7B-53FA48AD426BQ36847554-B5F024E1-ED0F-4D93-AAB2-A77ECE440285Q37963517-9BCE973D-B28D-4E06-84DA-EE1FFCC0F444Q38030605-36B83A6A-2C11-4953-A79A-98AA787BB1C6Q38209384-07681F87-4E2B-477D-B746-756E48927083Q38213813-76F54017-B13B-44C8-B677-A7DA9040657FQ38257762-3480A901-01EA-45CC-91CB-F7B7B28AA6FAQ38466437-50EF7E18-1FEF-4BD3-ABB1-C92A191FAB82Q38770436-30C66FCE-BB42-4597-A648-DE45DC1E31C5Q39006810-54EA5D09-75E8-4B40-AA71-0B9582AB0C75Q39336226-317FCC7D-C35B-4F51-9402-7A8350D12139Q40628384-3BE8F0E6-EAF4-43CB-B57A-6A5C91690D90Q45035228-8120440A-81AD-4235-9BCC-798FF9653BD0Q46180316-C4356B0D-9486-4C41-9D0D-C28D5AC89B2BQ46306526-8AAA3074-3554-4D5E-BAB0-D047B6057A17Q46320319-E33592AD-5C15-4745-9C6D-0A29FD0F2EB5Q47163092-1383B1CD-72E7-4D68-8349-873E7718D5F6Q47550799-1D27FFF2-C4B0-4C9F-8EEE-A7CA34CD7905Q48150902-28D33B37-4921-4A39-BC9A-3644CE01C793Q49178540-2C1B252E-2990-43BE-9971-0103AADFB651Q52645829-AD63452F-8B17-4D25-A1FA-09FD16E8D038Q57300007-39CFC015-513C-4F81-99F2-612944F976E0Q59001540-6D183B87-5BDC-4D9A-93D4-325889FF0C04
P2860
Cell-free nucleic acids as potential markers for preeclampsia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell-free nucleic acids as potential markers for preeclampsia.
@en
Cell-free nucleic acids as potential markers for preeclampsia.
@nl
type
label
Cell-free nucleic acids as potential markers for preeclampsia.
@en
Cell-free nucleic acids as potential markers for preeclampsia.
@nl
prefLabel
Cell-free nucleic acids as potential markers for preeclampsia.
@en
Cell-free nucleic acids as potential markers for preeclampsia.
@nl
P2093
P1433
P1476
Cell-free nucleic acids as potential markers for preeclampsia.
@en
P2093
P304
P356
10.1016/J.PLACENTA.2010.06.018
P478
P577
2011-02-01T00:00:00Z